-
Product Insights
Likelihood of Approval Analysis for Motor Neuron Diseases
Overview How likely is it that the drugs in Motor Neuron Diseases will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Motor Neuron Diseases Overview Motor neuron diseases (MNDs) encompass a group...
-
Product Insights
Likelihood of Approval Analysis for Amyotrophic Lateral Sclerosis
Overview How likely is it that the drugs in Amyotrophic Lateral Sclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amyotrophic Lateral Sclerosis Overview Amyotrophic lateral sclerosis (ALS), also known as...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Albumin (Human) in Decompensated Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Albumin (Human) in Decompensated Cirrhosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Albumin (Human) in Decompensated Cirrhosis Drug Details: Human Albumin (Albiomin, Albumin, Albutein, Plasbumin, Albuplan)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PBFT-02 in Frontotemporal Dementia (FTD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PBFT-02 in Frontotemporal Dementia (FTD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PBFT-02 in Frontotemporal Dementia (FTD) Drug Details: PBFT-02 is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Verdiperstat in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Verdiperstat in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Verdiperstat in Amyotrophic Lateral Sclerosis Drug Details: Verdiperstat (AZD-3241) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Albumin (Human) in Hepatic Encephalopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Albumin (Human) in Hepatic Encephalopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Albumin (Human) in Hepatic Encephalopathy Drug Details: Human Albumin (Albiomin, Albumin, Albutein, Plasbumin, Albuplan)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Celecoxib + Ciprofloxacin) in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Celecoxib + Ciprofloxacin) in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Celecoxib + Ciprofloxacin) in Alzheimer's Disease Drug Details: PrimeC...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Albumin (Human) in Ascites
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Albumin (Human) in Ascites report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Albumin (Human) in Ascites Drug Details: Human Albumin (Albiomin, Albumin, Albutein, Plasbumin, Albuplan) is obtained...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FB-418 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FB-418 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FB-418 in Parkinson's Disease Drug Details: FB-418 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FB-418 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FB-418 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FB-418 in Amyotrophic Lateral Sclerosis Drug Details: FB-418 is under development...